BlackRock’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.28K Hold
7,568
﹤0.01% 5226
2025
Q1
$8.33K Hold
7,568
﹤0.01% 5146
2024
Q4
$13.2K Hold
7,568
﹤0.01% 5096
2024
Q3
$10.4K Buy
7,568
+1
+0% +$1 ﹤0.01% 4930
2024
Q2
$44.7K Hold
7,567
﹤0.01% 4834
2024
Q1
$88.7K Sell
7,567
-35
-0.5% -$410 ﹤0.01% 4700
2023
Q4
$81.7K Sell
7,602
-5
-0.1% -$54 ﹤0.01% 4790
2023
Q3
$103K Hold
7,607
﹤0.01% 4771
2023
Q2
$190K Hold
7,607
﹤0.01% 4665
2023
Q1
$133K Hold
7,607
﹤0.01% 4810
2022
Q4
$86.5K Hold
7,607
﹤0.01% 5004
2022
Q3
$187K Buy
7,607
+64
+0.8% +$1.57K ﹤0.01% 4907
2022
Q2
$402K Hold
7,543
﹤0.01% 4753
2022
Q1
$538K Hold
7,543
﹤0.01% 4758
2021
Q4
$513K Buy
7,543
+35
+0.5% +$2.38K ﹤0.01% 4788
2021
Q3
$863K Hold
7,508
﹤0.01% 4532
2021
Q2
$1.13M Sell
7,508
-1,885
-20% -$284K ﹤0.01% 4408
2021
Q1
$1.6M Buy
9,393
+9,240
+6,039% +$1.58M ﹤0.01% 4298
2020
Q4
$14K Hold
153
﹤0.01% 4738
2020
Q3
$19K Hold
153
﹤0.01% 4622
2020
Q2
$20K Hold
153
﹤0.01% 4617
2020
Q1
$12K Hold
153
﹤0.01% 4616
2019
Q4
$20K Hold
153
﹤0.01% 4598
2019
Q3
$17K Hold
153
﹤0.01% 4613
2019
Q2
$21K Hold
153
﹤0.01% 4626
2019
Q1
$26K Hold
153
﹤0.01% 4514
2018
Q4
$22K Hold
153
﹤0.01% 4528
2018
Q3
$100K Hold
153
﹤0.01% 4389
2018
Q2
$320K Buy
153
+1
+0.7% +$2.09K ﹤0.01% 4157
2018
Q1
$425K Sell
152
-1
-0.7% -$2.8K ﹤0.01% 4029
2017
Q4
$681K Hold
153
﹤0.01% 3934
2017
Q3
$1.25M Buy
153
+20
+15% +$163K ﹤0.01% 3777
2017
Q2
$658K Sell
133
-505
-79% -$2.5M ﹤0.01% 3894
2017
Q1
$3.52M Buy
+638
New +$3.52M ﹤0.01% 3456
2016
Q4
Hold
0
-$5K 3591
2016
Q3
Hold
0
-$5K 3452
2016
Q2
Hold
0
3483